Walleye Trading
MDCO

Walleye Trading’s Medicines Co MDCO Stock Holding History

Walleye Trading’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-350,318
Closed -$29.8M – 4926
2019
Q4 		$29.8M Buy
350,318
+335,411
+2,250% +$22.4M 0.21% 71
2019
Q3 		$745K Buy
+14,907
New +$595K 0.01% 1819
2017
Q2 		– Sell
-4,965
Closed -$221K – 5198
2017
Q1 		$243 Buy
4,965
+4,232
+577% +$193K ﹤0.01% 2808
2016
Q4 		$25K Sell
733
-4,072
-85% -$144K ﹤0.01% 4008
2016
Q3 		$181K Sell
4,805
-4,426
-48% -$167K ﹤0.01% 2888
2016
Q2 		$310K Buy
+9,231
New +$325K ﹤0.01% 2618
2015
Q3 		– Sell
-589
Closed -$20.7K – 5741
2015
Q2 		$17K Buy
589
+326
+124% +$9.08K ﹤0.01% 4070
2015
Q1 		$7K Buy
+263
New +$7.39K ﹤0.01% 3785

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Walleye Trading's MDCO Position: Q1 2020 in Review

Walleye Trading sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 350,318 shares — an estimated $29.8M sold.

Walleye Trading first reported a position in MDCO in Q1 2015 and held it in 8 quarters. The position peaked at $29.8M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Walleye Trading reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Walleye Trading sold 350,318 Medicines Co shares in Q1 2020, an estimated $29.8M.
  • Walleye Trading first reported a position in Medicines Co in Q1 2015 and held it in 8 quarters.
  • Walleye Trading's Medicines Co position peaked at $29.8M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Walleye Trading's 13F filing for Q1 2020, filed 15 May 2020.